Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents

BACKGROUND: Despite successful clinical outcomes of biologic medications in patients with chronic rheumatic diseases, some considerable adverse effects such as infections remain a major concern. Possibility of tuberculosis (TB) reactivation over treatment with anti-tumor necrotizing factor (TNF) alp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hejazi, Mohammad-Esmaeil, Ahmadzadeh, Atefeh, Khabbazi, Alireza, Ebrahimi, Aliasghar, Farmani, Maryam, Hejazi, Yasin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331260/
https://www.ncbi.nlm.nih.gov/pubmed/32615992
http://dx.doi.org/10.1186/s12879-020-05166-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331260/
https://www.ncbi.nlm.nih.gov/pubmed/32615992
http://dx.doi.org/10.1186/s12879-020-05166-5

Ejemplares similares